Literature DB >> 25422452

Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation.

Simona Hefetz-Sela1, Ilan Stein1, Yair Klieger2, Rinnat Porat1, Moshe Sade-Feldman2, Farid Zreik1, Arnon Nagler3, Orit Pappo4, Luca Quagliata5, Eva Dazert6, Robert Eferl7, Luigi Terracciano5, Erwin F Wagner8, Yinon Ben-Neriah2, Michal Baniyash2, Eli Pikarsky9.   

Abstract

The inflamed tumor microenvironment plays a critical role in tumorigenesis. However, the mechanisms through which immune cells, particularly macrophages, promote tumorigenesis have only been partially elucidated, and the full scope of signaling pathways supplying macrophages with protumorigenic phenotypes still remain largely unknown. Here we report that germ-line absence of c-Jun N-terminal phosphorylation at serines 63 and 73 impedes inflammation-associated hepatocarcinogenesis, yet deleting c-Jun only in hepatocytes does not inhibit hepatocellular carcinoma (HCC) formation. Moreover, in human HCC-bearing livers, c-Jun phosphorylation is found in inflammatory cells, whereas it is mostly absent from malignant hepatocytes. Interestingly, macrophages in livers of mice with chronic hepatitis gradually switch their phenotype along the course of disease. Macrophage phenotype and density are dictated by c-Jun phosphorylation, in vitro and in vivo. Transition of macrophage phenotype, from antitumorigenic to protumorigenic, occurs before tumorigenesis, resulting in the production of various chemokines, including chemokine (C-C motif) ligand 17 (CCL17) and CCL22. Such signals, emanating from the liver microenvironment, direct the recruitment of regulatory T cells, which are known to facilitate HCC growth. Our findings identify c-Jun phosphorylation as a key mediator of macrophage education and point to the recruitment of immunosuppressive regulatory T cells as a possible protumorigenic mechanism.

Entities:  

Keywords:  HCC; M1 macrophages; M2 macrophages; Tregs; c-Jun phosphorylation

Mesh:

Substances:

Year:  2014        PMID: 25422452      PMCID: PMC4267378          DOI: 10.1073/pnas.1409700111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Cancer immunology.

Authors:  Cornelis J M Melief; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

3.  Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation.

Authors:  A Behrens; M Sibilia; E F Wagner
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

4.  The role of JNK in the development of hepatocellular carcinoma.

Authors:  Madhumita Das; David S Garlick; Dale L Greiner; Roger J Davis
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

Review 5.  Regulatory T cells in tumor immunity.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

Review 6.  Pathogenesis of hepatocellular carcinoma and molecular therapies.

Authors:  Beatriz Mínguez; Victoria Tovar; Derek Chiang; Augusto Villanueva; Josep M Llovet
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.

Authors:  Lijian Hui; Kurt Zatloukal; Harald Scheuch; Ewa Stepniak; Erwin F Wagner
Journal:  J Clin Invest       Date:  2008-11-06       Impact factor: 14.808

9.  FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1.

Authors:  Sang-Myeong Lee; Beixue Gao; Deyu Fang
Journal:  Blood       Date:  2008-01-25       Impact factor: 22.113

10.  c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity.

Authors:  Ewa Stepniak; Romeo Ricci; Robert Eferl; Grzegorz Sumara; Izabela Sumara; Martina Rath; Lijian Hui; Erwin F Wagner
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

View more
  25 in total

1.  A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation.

Authors:  Guoliang Zhang; Lin Guo; Cuixia Yang; Yiwen Liu; Yiqing He; Yan Du; Wenjuan Wang; Feng Gao
Journal:  Oncoimmunology       Date:  2016-04-29       Impact factor: 8.110

Review 2.  The Genetic Basis of Peyronie Disease: A Review.

Authors:  Amin S Herati; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-01-08

3.  Systematic Analysis of Neurotransmitter Receptors in Human Breast Cancer Reveals a Strong Association With Outcome and Uncovers HTR6 as a Survival-Associated Gene Potentially Regulating the Immune Microenvironment.

Authors:  Wei Zhang; Lintai Li; Jianxuan Li; Haiyan Yu; Fengping Zheng; Bin Yan; Wanxia Cai; Yumei Chen; Lianghong Yin; Donge Tang; Yong Xu; Yong Dai
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 4.  Functional and genetic deconstruction of the cellular origin in liver cancer.

Authors:  Jens U Marquardt; Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

5.  Restoring inflammatory balance as a potential preventive strategy for inflammation induced cancer.

Authors:  Simona Hefetz-Sela; Ilan Stein; Eli Pikarsky
Journal:  Oncoimmunology       Date:  2015-05-26       Impact factor: 8.110

6.  Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma.

Authors:  Myoung Sook Han; Tamera Barrett; Michael A Brehm; Roger J Davis
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

7.  Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.

Authors:  M Sadeghi; I Lahdou; H Oweira; V Daniel; P Terness; J Schmidt; K-H Weiss; T Longerich; P Schemmer; G Opelz; A Mehrabi
Journal:  Br J Cancer       Date:  2015-08-13       Impact factor: 7.640

8.  CD24-p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages.

Authors:  Dongling Li; Minling Hu; Ying Liu; Peiying Ye; Peishuang Du; Chi-Shan Li; Liang Cheng; Ping Liu; Jing Jiang; Lishan Su; Shengdian Wang; Pan Zheng; Yang Liu
Journal:  Cell Discov       Date:  2018-02-06       Impact factor: 10.849

9.  C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer.

Authors:  Moritz Rapp; Simon Grassmann; Michael Chaloupka; Patrick Layritz; Stephan Kruger; Steffen Ormanns; Felicitas Rataj; Klaus-Peter Janssen; Stefan Endres; David Anz; Sebastian Kobold
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

10.  Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels.

Authors:  Changfei Li; Mengmeng Deng; Jun Hu; Xin Li; Lizhao Chen; Ying Ju; Junli Hao; Songdong Meng
Journal:  Oncotarget       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.